Blood sugar falls further once exercise tops 150 minutes a week

HbA1c is the standard long-term marker of blood glucose control, and lowering it is a central goal in managing type 2 diabetes. Regular exercise was already known to improve glucose control, but a practical question remained unanswered: does it matter whether people receive a structured, supervised training programme or simply advice to be more active? And within structured training, do aerobic work, resistance work and the combination differ, and does the weekly amount matter? This review pooled the trial evidence to find out.

The authors searched six databases from January 1980 through February 2011 for randomised controlled trials of at least 12 weeks that tested structured exercise training or physical activity advice against a control group in people with type 2 diabetes. From 4191 articles retrieved, 47 trials with 8538 patients were included, and two reviewers independently extracted data and assessed quality. Changes in HbA1c between intervention and control groups were pooled, with structured training and advice-based interventions analysed separately.

Structured exercise training across 23 studies was associated with a 0.67% decline in HbA1c versus control. Broken down, structured aerobic exercise was linked to a 0.73% fall, resistance training to 0.57% and the combination to 0.51%. The dose pattern was clear: programmes over 150 minutes per week were associated with a 0.89% reduction, while 150 minutes or less was associated with 0.36%. Physical activity advice combined with dietary advice was linked to a 0.58% drop, and advice-based interventions overall to 0.43%, but physical activity advice alone was not associated with any HbA1c change.

This confirmed that exercise genuinely moves the key glucose marker in type 2 diabetes, and it sharpened the picture in two ways: structure beats advice, and weekly volume matters. The finding that advice alone achieved nothing without a dietary component complicates the common practice of simply telling patients to move more. As an association-level synthesis of varied trials, it cannot say which programme is ideal for any individual, and the trials differed substantially, which the authors acknowledge.

For anyone managing type 2 diabetes or its risk, this is a reason to think the format and the amount of exercise both matter, not just the intention to be active. Structured programmes, whether aerobic, resistance or both, were the versions linked to meaningful HbA1c falls, with the largest reductions above 150 minutes per week. It also suggests that movement and diet worked as a package in these trials, with neither piece of advice doing much alone. This is context for conversations with a clinician, not a treatment plan.